Cognitive development prior to onset of psychosis

Psychological Medicine

Volumn 48, Issue 3, 2018, Pages 392-403

  Mollon, J ^a   Reichenberg, A ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cognition; neurodevelopment; psychosis; schizophrenia

Indexed keywords

COGNITION; COGNITIVE DEFECT; COMPLICATION; HUMAN; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; PSYCHOSIS; SCHIZOPHRENIA;

COGNITION; COGNITIVE DYSFUNCTION; HUMANS; NEUROPSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 85025461884     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291717001970     Document Type: Review

References (87)

1. Agnew-Blais J, Seidman LJ (2013). Neurocognition in youth and young adults under age 30 at familial risk for schizophrenia: A quantitative and qualitative review. Cognitive Neuropsychiatry 18, 44-82.
2. Agnew-Blais JC, Buka SL, Fitzmaurice GM, Smoller JW, Goldstein JM, Seidman LJ (2015). Early childhood IQ trajectories in individuals later developing schizophrenia and affective psychoses in the New England Family Studies. Schizophrenia Bulletin 41, 817-823.
3. Ahmed AO, Mantini AM, Fridberg DJ, Buckley PF (2015). Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: A meta-analysis. Psychiatry Research 226, 1-13.
4. Alfimova M, Lezheko T, Golimbet V, Korovatseva G, Lavrushkina O, Kolesina N, Frolova L, Muratova A, Abramova L, Kaleda V (2007). Investigation of association of the brain-derived neurotrophic factor (BDNF) and a serotonin receptor 2A (5-HTR2A) genes with voluntary and involuntary attention in schizophrenia. Zhurnal nevrologii i psikhiatrii imeni SS Korsakova/Ministerstvo zdravookhraneniia i meditsinskoi promyshlennosti Rossiiskoi Federatsii, Vserossiiskoe obshchestvo nevrologov [i] Vserossiiskoe obshchestvo psikhiatrov 108, 62-69.
5. Amminger G, Schlögelhofer M, Lehner T, Looser Ott S, Friedrich M, Aschauer H (2000). Premorbid performance IQ deficit in schizophrenia. Acta Psychiatrica Scandinavica 102, 414-422.
6. Ang Y-G, Tan H-Y (2004). Academic deterioration prior to first episode schizophrenia in young Singaporean males. Psychiatry Research 121, 303-307.
7. Aylward E, Walker E, Bettes B (1984). Intelligence in schizophrenia: meta-analysis of the research. Schizophrenia Bulletin 10, 430-459.
8. Bass JL, Corwin M, Gozal D, Moore C, Nishida H, Parker S, Schonwald A, Wilker RE, Stehle S, Kinane TB (2004). The effect of chronic or intermittent hypoxia on cognition in childhood: A review of the evidence. Pediatrics 114, 805-816.
9. Bellinger DC (2008). Very low lead exposures and children's neurodevelopment. Current Opinion in Pediatrics 20, 172-177.
10. Bilder RM, Reiter G, Bates J, Lencz T, Szeszko P, Goldman RS, Robinson D, Lieberman JA, Kane JM (2006). Cognitive development in schizophrenia: follow-back from the first episode. Journal of Clinical and Experimental Neuropsychology 28, 270-282.
11. Bora E, Murray RM (2013). Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis Schizophrenia Bulletin 40, 744-755.
12. Cannon M, Caspi A, Moffitt TE, Harrington H, Taylor A, Murray RM, Poulton R (2002). Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Archives of General Psychiatry 59, 449-456.
13. Cannon M, Moffitt TE, Caspi A, Murray RM, Harrington H, Poulton R (2006). Neuropsychological performance at the age of 13 years and adult schizophreniform disorder. British Journal of Psychiatry 189, 463-464.
14. Cannon TD, Bearden CE, Hollister JM, Rosso IM, Sanchez LE, Hadley T (2000). Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: A prospective cohort study. Schizophrenia Bulletin 26, 379.
15. Clarke MC, HarleyM, CannonM (2006). The role of obstetric events in schizophrenia. Schizophrenia Bulletin 32, 3-8.
16. Crow T, Done D, Sacker A (1995). Chidhood precursors of psychiosis as clues to its evolutionary orgins. European Archives of Psychiatry and Clinical Neuroscience 245, 61-69.
17. David AS, Malmberg A, Brandt L, Allebeck P, Lewis G (1997). IQ and risk for schizophrenia: A population-based cohort study. Psychological Medicine 27, 1311-1323.
18. De Luca CR, Wood SJ, Anderson V, Buchanan J-A, Proffitt TM, Mahony K, Pantelis C (2003). Normative data from the CANTAB. I: development of executive function over the lifespan. Journal of Clinical and Experimental Neuropsychology 25, 242-254.
19. Ellman LM, Yolken RH, Buka SL, Torrey EF, Cannon TD (2009). Cognitive functioning prior to the onset of psychosis: The role of fetal exposure to serologically determined influenza infection. Biological Psychiatry 65, 1040-1047.
20. Forsyth JK, Ellman LM, Tanskanen A, Mustonen U, Huttunen MO, Suvisaari J, Cannon TD (2013). Genetic risk for schizophrenia, obstetric complications, and adolescent school outcome: evidence for gene-environment interaction. Schizophrenia Bulletin 39, 1067-1076.
21. Fowler T, Zammit S, Owen MJ, Rasmussen F (2012). A population-based study of shared genetic variation between premorbid IQ and psychosis among male twin pairs and sibling pairs from Sweden. Archives of General Psychiatry 69, 460-466.
22. Fuller R, Nopoulos P, Arndt S, O'Leary D, Ho B-C, Andreasen NC (2002). Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. American Journal of Psychiatry 159, 1183-1189.
23. Golimbet V (2007). Molecular genetics of cognitive deficit in schizophrenia. Molekuliarnaia Biologiia 42, 830-839.
24. Gothelf D, Eliez S, Thompson T, Hinard C, Penniman L, Feinstein C, Kwon H, Jin S, Jo B, Antonarakis SE, Morris MA, Reiss AL (2005). COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11. 2 deletion syndrome. Nature Neuroscience 8, 1500-1502.
25. Gountouna V-E, Hafferty J, Campbell A, Porteous D, McIntosh A, Nicodemus K (2017). 911-gene-by-environment analyses reveal obstetric complications interact with genetics to influence psychopathology and personality. Biological Psychiatry 81, S368.
26. Green MJ, Chia T-Y, Cairns MJ, Wu J, Tooney PA, Scott RJ, Carr VJ, Bank ASR (2014). Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia. Journal of Psychiatric Research 49, 43-50.
27. Greenwood TA, Lazzeroni LC, Murray SS, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Gur RE, Gur RC, Hardiman G (2011). Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the consortium on the genetics of schizophrenia. American Journal of Psychiatry 168, 930-946.
28. Gunnell D, Harrison G, Rasmussen F, Fouskakis D, Tynelius P (2002). Associations between premorbid intellectual performance, early-life exposures and early-onset schizophrenia. British Journal of Psychiatry 181, 298-305.
29. Heinrichs RW, Zakzanis KK (1998). Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropsychology 12, 426.
30. Ho B-C, Milev P, O'Leary DS, Librant A, Andreasen NC, Wassink TH (2006). Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Archives of General Psychiatry 63, 731-740.
31. Hubbard L, Tansey KE, Rai D, Jones P, Ripke S, Chambert KD, Moran JL, McCarroll SA, Linden DE, Owen MJ (2015). Evidence of common genetic overlap between schizophrenia and cognition. Schizophrenia Bulletin 42, 832-842.
32. Isohanni I, Järvelin M-R, Nieminen P, Jones P, Rantakallio P, Jokelainen J, Isohanni M (1998). School performance as a predictor of psychiatric hospitalization in adult life. A 28-year follow-up in the Northern Finland 1966 Birth Cohort. Psychological Medicine 28, 967-974.
33. Jablensky A, Morar B, Wiltshire S, Carter K, Dragovic M, Badcock JC, Chandler D, Peters K, Kalaydjieva L (2011). Polymorphisms associated with normal memory variation also affect memory impairment in schizophrenia. Genes, Brain and Behavior 10, 410-417.
34. Jones P, Murray R, Jones P, Rodgers B, Marmot M (1994). Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 344, 1398-1402.
35. Karayiorgou M, Simon TJ, Gogos JA (2010). 22q11. 2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nature Reviews Neuroscience 11, 402-416.
36. Kauppi K, Westlye LT, Tesli M, Bettella F, Brandt CL, Mattingsdal M, Ueland T, Espeseth T, Agartz I, Melle I, Djurovic S, Andreassen OA (2015). Polygenic risk for schizophrenia associated with working memory-related prefrontal brain activation in patients with schizophrenia and healthy controls. Schizophrenia Bulletin 41, 736-743.
37. Kendler KS, Ohlsson H, Mezuk B, Sundquist K, Sundquist J (2016). A Swedish National Prospective and co-relative study of school achievement at age 16, and risk for schizophrenia, other nonaffective psychosis, and bipolar illness. Schizophrenia Bulletin 42, 77-86.
38. Kendler KS, Ohlsson H, Sundquist J, Sundquist K (2015). IQ and schizophrenia in a Swedish national sample: Their causal relationship and the interaction of IQ with genetic risk. American Journal of Psychiatry 172, 259-265.
39. Khandaker GM, Barnett JH, White IR, Jones PB (2011). A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophrenia Research 132, 220-227.
40. Kirov G, Pocklington A, Holmans P, Ivanov D, Ikeda M, Ruderfer D, Moran J, Chambert K, Toncheva D, Georgieva L (2012). De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Molecular Psychiatry 17, 142.
41. Koenen KC, Moffitt TE, Roberts AL, Martin LT, Kubzansky L, Harrington H, Poulton R, Caspi A (2009). Childhood IQ and adult mental disorders: A test of the cognitive reserve hypothesis. American Journal of Psychiatry 166, 50-57.
42. Kremen WS, Vinogradov S, Poole JH, Schaefer CA, Deicken RF, Factor-Litvak P, Brown AS (2010). Cognitive decline in schizophrenia from childhood to midlife: A 33-year longitudinal birth cohort study. Schizophrenia Research 118, 1-5.
43. Kunugi H, Nanko S, Murray RM (2001). Obstetric complications and schizophrenia: prenatal underdevelopment and subsequent neurodevelopmental impairment. British Journal of Psychiatry 178, s25-s29.
44. Lencz T, Knowles E, Davies G, Guha S, Liewald DC, Starr JM, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, Mukherjee S, DeRosse P, Lundervold A, Steen VM, John M, Espeseth T, Raikkonen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Ikeda M, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Horan M, Donohoe G, Morris D, Corvin A, Gill M, Pendleton N, Iwata N, Darvasi A, Bitsios P, Rujescu D, Lahti J, Hellard SL, Keller MC, Andreassen OA, Deary IJ, Glahn DC, Malhotra AK (2014). Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: A report from the Cognitive Genomics consorTium (COGENT). Molecular Psychiatry 19, 168-174.
45. Lubman DI, Cheetham A, Yucel M (2015). Cannabis and adolescent brain development. Pharmacology & Therapeutics 148, 1-16.
46. Maccabe JH (2008). Population-based cohort studies on premorbid cognitive function in schizophrenia. Epidemiologic Reviews 30, 77-83.
47. MacCabe JH, Wicks S, Lofving S, David AS, Berndtsson A, Gustafsson JE, Allebeck P, Dalman C (2013). Decline in cognitive performance between ages 13 and 18 years and the risk for psychosis in adulthood: A Swedish longitudinal cohort study in males. JAMA Psychiatry 70, 261-270.
48. McIntosh AM, Gow A, Luciano M, Davies G, Liewald DC, Harris SE, Corley J, Hall J, Starr JM, Porteous DJ (2013). Polygenic risk for schizophrenia is associated with cognitive change between childhood and old age. Biological Psychiatry 73, 938-943.
49. Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ (2009). Neurocognition in first-episode schizophrenia: A meta-analytic review. Neuropsychology 23, 315.
50. Modabbernia A, Velthorst E, Gennings C, De Haan L, Austin C, Sutterland A, Mollon J, Frangou S, Wright R, Arora M (2016). Early-life metal exposure and schizophrenia: A proof-of-concept study using novel tooth-matrix biomarkers. European Psychiatry 36, 1-6.
51. Mortensen EL, Sørensen HJ, Jensen HH, Reinisch JM, Mednick SA (2005). IQ and mental disorder in young men. British Journal of Psychiatry 187, 407-415.
52. Murray RM, Lewis SW (1987). Is schizophrenia a neurodevelopmental disorder British Medical Journal (Clinical research ed.) 295, 681.
53. Murray RM, Sham P, Van Os J, Zanelli J, Cannon M, McDonald C (2004). A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophrenia Research 71, 405-416.
54. Nicodemus KK, Elvevåg B, Foltz PW, Rosenstein M, Diaz-Asper C, Weinberger DR (2014). Category fluency, latent semantic analysis and schizophrenia: A candidate gene approach. Cortex 55, 182-191.
55. Niendam TA, Bearden CE, Rosso IM, Sanchez LE, Hadley T, Nuechterlein KH, Cannon TD (2003). A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings. American Journal of Psychiatry 160, 2060-2062.
56. Osler M, Lawlor DA, Nordentoft M (2007). Cognitive function in childhood and early adulthood and hospital admission for schizophrenia and bipolar disorders in Danish men born in 1953. Schizophrenia Research 92, 132-141.
57. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748-752.
58. Rabin RA, Zakzanis KK, George TP (2011). The effects of cannabis use on neurocognition in schizophrenia: A meta-analysis. Schizophrenia Research 128, 111-116.
59. Reichenberg A, Caspi A, Harrington H, Houts R, Keefe RS, Murray RM, Poulton R, Moffitt TE (2010). Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: A 30-year study. American Journal of Psychiatry 167, 160-169.
60. Reichenberg A, Harvey PD (2007). Neuropsychological impairments in schizophrenia: integration of performance-based and brain imaging findings. Psychological Bulletin 133, 833-858.
61. Reichenberg A, Rabinowitz J, Weiser M, Mark M, Kaplan Z, Davidson M (2000). Premorbid functioning in a national population of male twins discordant for psychoses. American Journal of Psychiatry 157, 1514-1516.
62. Reichenberg A, Weiser M, Caspi A, Knobler HY, Lubin G, Harvey PD, Rabinowitz J, Davidson M (2006). Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders. Journal of Clinical and Experimental Neuropsychology 28, 193-207.
63. Reichenberg A, Weiser M, Rabinowitz J, Caspi A, Schmeidler J, Mark M, Kaplan Z, Davidson M (2002). A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. American Journal of Psychiatry 159, 2027-2035.
64. Reuben A, Caspi A, Belsky DW, Broadbent J, Harrington H, Sugden K, Houts RM, Ramrakha S, Poulton R, Moffitt TE (2017). Association of childhood blood lead levels with cognitive function and socioeconomic status at age 38 years and with IQ change and socioeconomic mobility between childhood and adulthood. JAMA 317, 1244-1251.
65. Schizophrenia Working Group of the Psychiatric Genomics C (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427.
66. Seidman LJ, Buka SL, Goldstein JM, Horton NJ, Rieder RO, Tsuang MT (2000). The relationship of prenatal and perinatal complications to cognitive functioning at age 7 in the New England Cohorts of the National Collaborative Perinatal Project. Schizophrenia Bulletin 26, 309.
67. Seidman LJ, Buka SL, Goldstein JM, Tsuang MT (2006). Intellectual decline in schizophrenia: evidence from a prospective birth cohort 28 year follow-up study. Journal of Clinical and Experimental Neuropsychology 28, 225-242.
68. Seidman LJ, Cherkerzian S, Goldstein JM, Agnew-Blais J, Tsuang MT, Buka SL (2013). Neuropsychological performance and family history in children at age 7 who develop adult schizophrenia or bipolar psychosis in the New England Family Studies. Psychological Medicine 43, 119-131.
69. Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, Tooley K, Presumey J, Baum M, Van Doren V, Genovese G, Rose SA, Handsaker RE, Schizophrenia Working Group of the Psychiatric Genomics C, Daly MJ, Carroll MC, Stevens B, McCarroll SA (2016). Schizophrenia risk from complex variation of complement component 4. Nature 530, 177-183.
70. Shi J, Han P, Kuniyoshi SM (2014). Cognitive impairment in neurological diseases: lessons from apolipoprotein E. Journal of Alzheimer's Disease 38, 1-9.
71. Stefansson H, Meyer-Lindenberg A, Steinberg S, Magnusdottir B, Morgen K, Arnarsdottir S, Bjornsdottir G, Walters GB, Jonsdottir GA, Doyle OM, Tost H, Grimm O, Kristjansdottir S, Snorrason H, Davidsdottir SR, Gudmundsson LJ, Jonsson GF, Stefansdottir B, Helgadottir I, Haraldsson M, Jonsdottir B, Thygesen JH, Schwarz AJ, Didriksen M, Stensbol TB, Brammer M, Kapur S, Halldorsson JG, Hreidarsson S, Saemundsen E, Sigurdsson E, Stefansson K (2014). CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature 505, 361-366.
72. Steinhausen H-CE, Strauss J, Strohmaier J, Stroup T, Sutcliffe J, Szatmari P, Szelinger S, Thirumalai S, Thompson RC, Tozzi F (2013). Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. Lancet 381, 1371-1379.
73. Stone JL, O'Donovan MC, Gurling H, Kirov GK, Blackwood DH, Corvin A, Craddock NJ, Gill M, Hultman CM, Lichtenstein P (2008). Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455, 237-241.
74. Tiihonen J, Haukka J, Henriksson M, Cannon M, Kieseppä T, Laaksonen I, Sinivuo J, Lönnqvist J (2005). Premorbid intellectual functioning in bipolar disorder and schizophrenia: results from a cohort study of male conscripts. American Journal of Psychiatry 162, 1904-1910.
75. Toulopoulou T, Picchioni M, Rijsdijk F, Hua-Hall M, Ettinger U, Sham P, Murray R (2007). Substantial genetic overlap between neurocognition and schizophrenia: genetic modeling in twin samples. Archives of general psychiatry 64, 1348-1355.
76. Trotta A, Murray R, MacCabe J (2015). Do premorbid and post-onset cognitive functioning differ between schizophrenia and bipolar disorder A systematic review and meta-analysis. Psychological Medicine 45, 381-394.
77. Twamley EW, Hua JP, Burton CZ, Vella L, Chinh K, Bilder RM, Kelsoe JR (2014). Effects of COMT genotype on cognitive ability and functional capacity in individuals with schizophrenia. Schizophrenia Research 159, 114-117.
78. Urfer-Parnas A, Mortensen EL, Saebye D, Parnas J (2010). Pre-morbid IQ in mental disorders: A Danish draft-board study of 7486 psychiatric patients. Psychological Medicine 40, 547-556.
79. Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, Bloomfield MA, Curran HV, Baler R (2016). Effects of Cannabis use on human behavior, including cognition, motivation, and psychosis: A review. JAMA Psychiatry 73, 292-297.
80. Vorstman JA, Breetvelt EJ, Duijff SN, Eliez S, Schneider M, Jalbrzikowski M, Armando M, Vicari S, Shashi V, Hooper SR, Chow EW, Fung WL, Butcher NJ, Young DA, McDonald-McGinn DM, Vogels A, van Amelsvoort T, Gothelf D, Weinberger R, Weizman A, Klaassen PW, Koops S, Kates WR, Antshel KM, Simon TJ, Ousley OY, Swillen A, Gur RE, Bearden CE, Kahn RS, Bassett AS, International Consortium on B & Behavior in 22q11. 2 Deletion S (2015). Cognitive decline preceding the onset of psychosis in patients with 22q11. 2 deletion syndrome. JAMA Psychiatry 72, 377-385.
81. Walker NP, McConville PM, Hunter D, Deary IJ, Whalley LJ (2002). Childhood mental ability and lifetime psychiatric contact: A 66-year follow-up study of the 1932 Scottish Mental Ability Survey. Intelligence 30, 233-245.
82. Weinberger DR (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry 44, 660.
83. Welham J, Scott J, Williams G, Najman J, Bor W, O'Callaghan M, McGrath J (2010). The antecedents of nonaffective psychosis in a birthcohort, with a focus onmeasures related to cognitive ability, attentional dysfunction and speech problems. Acta Psychiatrica Scandinavica 121, 273-279.
84. Woodberry K, Giuliano A, Seidman L (2008). Premorbid IQ in schizophrenia: A meta-analytic review. American Journal of Psychiatry 165, 579-587.
85. Yucel M, Bora E, Lubman DI, Solowij N, Brewer WJ, Cotton SM, Conus P, Takagi MJ, Fornito A, Wood SJ, McGorry PD, Pantelis C (2012). The impact of cannabis use on cognitive functioning in patients with schizophrenia: A meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia Bulletin 38, 316-330.
86. Zai G, Robbins TW, Sahakian BJ, Kennedy JL (2016). A review of molecular genetic studies of neurocognitive deficits in schizophrenia. Neuroscience & Biobehavioral Reviews 72, 50-67.
87. Zammit S, Allebeck P, David AS, Dalman C, Hemmingsson T, Lundberg I, Lewis G (2004). A longitudinal study of premorbid IQ score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Archives of General Psychiatry 61, 354-360.